Minimal Residual Disease (MRD) follow up of MM patients obtaining stringent complete remission (sCR) in the NMSG/EMN02 clinical trial – defining sCR numbers and prediction of disease progression by multiparametric flow cytometry (MFC).
Year: 2018
Type: article
Authors: Hans Erik Johnsen, Alexander Schmitz, Julie Støve Bødker, Pieter Sonneveld, Davine Hofste op Bruinink, Bronno van der Holt, Vincent H. J. van der Velden, Niels Abildgaard, Lucia Ahlberg, Niels Smedegaard Andersen, Björn Andréasson, Lena Brandefors, Hans Christiansen, S. Faxoe, C. Fransson, M. Friestad, Hans Gregersen, Y. Hammerlund, Maria Hansson, Einar Haukaas, Mark Hector, Carsten Helleberg, Mette Holst, Andreas Jönsson, V. Karlsson, Anja Klostergaard, Susanne K. Kjær, Birgitta Lauri, Stig Lenhoff, I. Lonn, E. Myhr, B. Højlund Pedersen, Rosaria Renna, T Sjögren, Asta Svirskaite, Damian Szatkowski, S. Vangsted, Anders Waage, Fredrik Schjesvold, U-H Mellqvist, Helle Høholt, Louise Hvilshøj Madsen, Henning Sand Christensen, Rasmus Froberg Brøndum, Martin Bøgsted, Karen Dybkær
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W2934682707